A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023. - Jallorina A; Vij K; Wan L; Thomas J; Drum D; Glick SA; Lee-Wong MF (Journal of cardiovascular pharmacology, 2025)